Synairgen plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was GBP 17.65 million compared to GBP 48.66 million a year ago. Basic loss per share from continuing operations was GBP 0.0876 compared to GBP 0.2428 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.49 GBX | -1.52% | -3.85% | +8.62% |
2023 | FTSE 100 Finishes Slightly Lower After Steady Session | DJ |
2023 | Synairgen names Phytome's Joseph Colliver as CFO | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.62% | 16.28M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SNG Stock
- News Synairgen plc
- Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2022